Yillik farmatsevtika preparatlari savdosi - Annual pharmaceutical drug sales - Wikipedia

Yillik savdo (million dollar)

Dori-darmonSavdo nomiBirlamchi ko'rsatkichKompaniya20152014201320122011201020092008[1][2][3][4][5][6]2007[7][8][9][10][11][12]2006[13][14][15][16][17][18]2005[19][20][21][22][23]2004[24][25][26][27]2003[28][29][30][31]2002[32][33][34][35]2001[36]2000[37][38]
atorvastatinLipitorLDL xolesterolini kamaytirishPfizer$12,401$12,675$12,886$12,187$10,862$9,231$7,972$6,448$5,028
sunitinib malateSutentRivojlangan va / yoki metastatik buyrak hujayrasi karsinomasi (mRCC) va refrakter gastrointestinal stromal o'smalar (GIST)Pfizer$847$581$219
irinotekanCamptosarMetastatik kolorektal saratonPfizer$563$969$903$910$554$299
bimatoprostLumiganOchiq burchakli glaukoma yoki okulyar gipertenziyaAllergan$426.2$391.7$327.5$267.6$232.9$181.3$123$35.4
exemestaneAromasinKo'krak bezi saratoniPfizer$465$401$320$247$143$58
epirubitsinZo'ravonlikKo'krak bezi saratoniPfizer$312$367$344$216
trastuzumabGertseptinHER2-musbat metastatik ko'krak bezi saratoniGenentech$1,382$1,287$1,234$747.2$483.2$424.8$385.2$346.7$276
gemtsitabinGemzarTuxumdon saratoni, kichik hujayrali bo'lmagan o'pka saratoni (NSCLC), metastatik ko'krak saratoni (MBC) va oshqozon osti bezi saratoniEli Lilly & Co.$1,719.8$1,592.4$1,408.1$1,334.5$1,214.4$1,021.7$875$723$559.3
bevacizumabAvastinMetastatik kolorektal saraton, kichik bo'lmagan hujayrali o'pka saratoni (NSCLC), buyrak hujayrasi karsinomasi, HER2-salbiy ko'krak bezi saratoniGenentech$2,686$2,296$1,746$1,132$554.6
erlotinibTarcevaIlg'or (metastatik) kichik hujayrali bo'lmagan o'pka saratoni (NSCLC)Genentech$457$417$402$274.9$13.3
brimonidinAlphaganOchiq burchakli glaukoma yoki okulyar gipertenziyaAllergan$286.8$248.5$250.9
rituximabRituxanXodkin bo'lmagan limfoma va revmatoid artritGenentech$2,587$2,285$2,071$1,831.4$1,574$1,360.2$1,162.9$818.6
ranibizumabLucentisYoshga bog'liq makula dejeneratsiyasi (AMD)Genentech$875$815$380
omalizumabXolairAstmaGenentech$517$472$425$320.6$187.6$25.1
somatropinNutropinO'sish gormoni etishmovchiligi, surunkali buyrak kasalligiGenentech$358$371$378$370.5$348.8$319.5
dornase alfaPulmozimKistik fibroz (CF)Genentech$257$223$199$186.5$157.1$143.7$138.1$123
efalizumabRaptivaBlyashka toshbaqa kasalligiGenentech$108$107$90$79.2$52.4$1.4
montelukastSingulairAstmaMerck$4,336.9$4,266.3$3,579$2,975.6$2,622
natriy alendronatFosamaksPostmenopozal osteoporozMerck$1,552.7$3,049$3,134.4$3,191.2$3,159.7
sitagliptinJanuviya2-toifa diabetMerck$1,397.1$667.5$42.9
simvastatinZokorLDL xolesterolini kamaytirishMerck$660.1$876.5$2,802.7$4,381.7$5,196.5
rizatriptan benzoatMaxaltO'chokli og'riqMerck$529.2$467.3$406.4$348.4$309.9
finasteridPropeciaSoch to'kilishiMerck$429.1$405.4$351.8$291.9$270.2
etorikoksibArkoksiArtroz va revmatoid artritMerck$377.3$329.1$265.4$218.2
sitagliptin /metformin HClJanumet2-toifa diabetMerck$351.1$86.4
finasteridProscarProstatitning yaxshi giperplaziyasi (prostata kattalashgan)Merck$323.5$411$618.5$741.4$733.1
epchilO'zgartirishKimyoterapiya natijasida ko'ngil aynish va gijjalar oldini olishMerck$263.8$204.2$130.8$87
olanzapinZipreksaShizofreniyaEli Lilly & Co.$4,696.1$4,761$4,363.6$4,202.3$4,419.8$4,276.9$3,689$3,087$2,349.5
duloksetin HClCymbaltaDepressiya va umumiy bezovtalik buzilishiEli Lilly & Co.$2,697.1$2,102.9$1,316.4$679.7$93.9
insulin lisproHumalogKattalardagi 1-toifa diabetEli Lilly & Co.$1,735.8$1,474.6$1,299.5$1,197.7$1,101.6$1,021.3$834$628$350.2
pemetreksedAlimtaMahalliy rivojlangan yoki metastatik nonsquamous kichik bo'lmagan hujayrali o'pka saratoni (NSCLC)Eli Lilly & Co.$1,154.7$854$611.8$463.2$142.6
raloksifen HClEvistaOsteoporozEli Lilly & Co.$1,075.6$1,090.7$1,045.3$1,036.1$1,012.7$922.1$822$665$521.5
insulin izofanGumulinQandli diabetEli Lilly & Co.$1,063.2$985.2$925.3$1,004.7$997.7$1,060.4$1,004$1,061$1,114.5
teriparatidForteoOsteoporozEli Lilly & Co.$778.7$709.3$594.3$389.3$238.6$65.3
atomoksetin HClStratteraDiqqat etishmasligi / giperaktivlik buzilishi (DEHB)Eli Lilly & Co.$579.5$569.4$579$552.1$666.7$370.3
timololIstalolOchiq burchakli glaukomaIsta farmatsevtika$14.6$11.3$8.3$2.6
bromfenakXibromOkulyar yallig'lanishIsta farmatsevtika$63$42.1$20.2$5.3
gialuronidazaVitrazTarqatish agentiIsta farmatsevtika$5.2$5.2$4.2$2.5
rivaroksabanXareltoChuqur tomir tromboziJonson va Jonson[39]$1,868$1,522$864$239$25

Izohlar

  1. ^ [1], Genentech 2008 10-K.
  2. ^ [2], Pfizer 2008 10-K.
  3. ^ [3], Eli Lilly & Co. 2008 yil 10-K.
  4. ^ [4], Allergan 2008 10-K.
  5. ^ [5], Merck 2008 10-K.
  6. ^ [6], Ista farmatsevtika 2008 10-K.
  7. ^ [7], Genentech 2007 10-K.
  8. ^ [8], Pfizer 2007 10-K.
  9. ^ [9], Eli Lilly & Co. 2007 10-K.
  10. ^ [10], Allergan 2007 10-K.
  11. ^ [11], Merck 2007 10-K.
  12. ^ [12], Ista farmatsevtika 2007 10-K.
  13. ^ [13], Genentech 2006 10-K.
  14. ^ [14], Pfizer 2006 10-K.
  15. ^ [15], Eli Lilly & Co. 2006 yil 10-K.
  16. ^ [16], Allergan 2006 10-K.
  17. ^ [17], Merck 2006 yil 10-K.
  18. ^ [18], Ista farmatsevtika 2006 10-K.
  19. ^ [19], Genentech 2005 10-K.
  20. ^ [20], Pfizer 2005 10-K.
  21. ^ [21], Eli Lilly & Co. 2005 yil 10-K.
  22. ^ [22], Allergan 2005 10-K.
  23. ^ [23], Merck 2005 10-K.
  24. ^ [24], Genentech 2004 10-K.
  25. ^ [25], Pfizer 2004 10-K.
  26. ^ [26], Eli Lilly & Co. 2004 yil 10-K.
  27. ^ [27], Allergan 2004 10-K.
  28. ^ [28], Genentech 2003 10-K.
  29. ^ [29], Pfizer 2003 10-K.
  30. ^ [30], Eli Lilly & Co. 2003 yil 10-K.
  31. ^ [31], Allergan 2003 10-K.
  32. ^ [32], Genentech 2002 10-K.
  33. ^ [33], Pfizer 2002 10-K.
  34. ^ [34], Eli Lilly & Co. 2002 yil 10-K.
  35. ^ [35], Allergan 2002 10-K.
  36. ^ [36], Pfizer 2001 10-K.
  37. ^ [37], Genentech 2000 10-K.
  38. ^ [38], Eli Lilly & Co. 2000 yil 10-K.
  39. ^ "SEC Filings - Jonson va Jonson". www.investor.jnj.com. Arxivlandi asl nusxasi 2016-04-09 da. Olingan 2016-03-25.